Literature DB >> 12081564

Inhibition of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1.

Hongli Lin1, Xiangmei Chen, Jianzhong Wang, Zhiheng Yu.   

Abstract

BACKGROUND: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an important inhibitor of extracellular matrix degradation. Recently, it was reported that TIMP-1 also could inhibit apoptosis in B type lymphocyte. This study was designed to examine the effects of TIMP-1 on mesangial cell apoptosis.
METHODS: The full-length cDNA of TIMP-1 was cloned and used to construct two recombinant vectors, TIMP-1S and TIMP-1AS, encoding sense TIMP-1 and antisense TIMP-1, respectively. The vectors were transfected into rat mesangial cells (RMC) and their expressions detected by Northern and Western blotting. Apoptosis was induced by serum deprivation, and was monitored for DNA fragmentation by TUNEL assay and DNA laddering. In addition, the expression of endogenous TIMP-1, matrix metalloprotein-2 (MMP-2), and MMP-9, as well as apoptosis-related genes Bcl-2 and Bax were investigated.
RESULTS: TIMP-1AS transfection induced a suppression of TIMP-1 expression accompanied by an earlier onset of apoptosis, and TIMP-1S transfection induced TIMP-1 over-expression accompanied by a much later onset of apoptosis. A neutralizing antibody of TIMP-1 restored the sensitivity of TIMP-1S-transfected RMC to serum deprivation, but a synthetic matrix metalloproteinase inhibitor BB-94 did not influence the sensitivity of TIMP-1S-transfected RMC to serum deprivation. Finally, TIMP-1 over-expression inhibited the expression of Bax but with no effect on the expression of Bcl-2.
CONCLUSION: TIMP-1 inhibits the serum deprivation-induced apoptosis in RMC, in which Bax might be involved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081564     DOI: 10.1046/j.1523-1755.2002.00403.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.

Authors:  Sergio Duarte; Takashi Hamada; Naohisa Kuriyama; Ronald W Busuttil; Ana J Coito
Journal:  Hepatology       Date:  2012-07-11       Impact factor: 17.425

2.  Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression.

Authors:  Yang Lu; Shuxin Liu; Shujia Zhang; Guangyan Cai; Hongwei Jiang; Huabin Su; Xiaofan Li; Quan Hong; Xueguang Zhang; Xiangmei Chen
Journal:  Mol Cells       Date:  2011-01-06       Impact factor: 5.034

3.  Nuclear localization of catalytically active MMP-2 in endothelial cells and neurons.

Authors:  Satyesh K Sinha; Kamlesh Asotra; Hiroyasu Uzui; Santosh Nagwani; Vivek Mishra; Tripathi B Rajavashisth
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

Review 4.  Matrix metalloproteinases in kidney homeostasis and diseases.

Authors:  Roderick J Tan; Youhua Liu
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-04

5.  Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.

Authors:  Milan Chromek; Kjell Tullus; Joachim Lundahl; Annelie Brauner
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina.

Authors:  Hwa Sun Kim; Andrew Vargas; Yun Sung Eom; Justin Li; Kyra L Yamamoto; Cheryl Mae Craft; Eun-Jin Lee
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.